Nexstim Plc (FRA:5NX)

Market Cap	93.77M +41.1%
Revenue (ttm)	11.63M +24.2%
Net Income	-282.99K
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	49.35
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	3
Open	12.65
Previous Close	12.55
Day's Range	12.65 - 12.65
52-Week Range	6.64 - 16.20
Beta	n/a
RSI	44.35
Earnings Date	Feb 26, 2026

About Nexstim

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company’s transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provides Navigated Brain Stimulation (NBS) 5 system, a TMS system for the pre-surgical mapping of the motor cortex and the speech areas of the brain; and NB...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 40
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5NX

Financial Performance

In 2024, Nexstim's revenue was 10.21 million, an increase of 18.97% compared to the previous year's 8.58 million. Losses were -892,285, -32.79% less than in 2023.